Ligand-Dependent Inhibition and Reversal of Tau Filament Formation

Biochemistry

Volumn 43, Issue 10, 2004, Pages 2879-2887

  Chirita, Carmen ^a   Necula, Mihaela ^a   Kuret, Jeff ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; DISEASE CONTROL; NEUROLOGY; PHARMACODYNAMICS; PROTEINS; STOICHIOMETRY; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY;

PHARMACOLOGY;

BIOCHEMISTRY;

3 (2 HYDROXYETHYL) 2 [2 [[3 (2 HYDROXYETHYL) 5 METHOXY 2 BENZOTHIAZOLYLIDENE]METHYL] 1 BUTENYL] 5 METHOXYBENZOTHIAZOLIUM; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; ARACHIDONIC ACID; LIGAND; N 774; PROTEIN INHIBITOR; TAU PROTEIN; TAU PROTEIN AGGREGATION INHIBITOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; IC 50; KINETICS; NERVE DEGENERATION; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DISAGGREGATION; STOICHIOMETRY; TRANSMISSION ELECTRON MICROSCOPY;

ARACHIDONIC ACID; BENZOTHIAZOLES; CARBOCYANINES; COLORING AGENTS; HUMANS; LIGANDS; MICROSCOPY, ELECTRON; MICROSPHERES; NEUROFILAMENT PROTEINS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; TAU PROTEINS; THIAZOLES;

ANIMALIA;

EID: 1542327644     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi036094h     Document Type: Article

References (60)

1. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders, Brain. Res. Brain. Res. Rev. 33, 95-130.
2. Braak, H., and Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol. (Berlin) 82, 239-259.
3. Braak, E., Braak, H., and Mandelkow, E. M. (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads, Acta Neuropathol. (Berlin) 87, 554-567.
4. Feany, M. B., and Dickson, D. W. (1996) Neurodegenerative disorders with extensive tau pathology: a comparative study and review, Ann. Neurol. 40, 139-148.
5. Spillantini, M. G., Van Swieten, J. C., and Goedert, M. (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), Neurogenetics 2, 193-205.
6. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Paul Murphy, M., Baker, M., Yu, X., Duff, K., Hardy, J., Corral, A., Lin, W. L., Yen, S. H., Dickson, D. W., Davies, P., and Hutton, M. (2000) Neurofibrillary tangles, amyotrophy, and progressive motor disturbance in mice expressing mutant (P301L) tau protein, Nat. Genet. 25, 402-405.
7. Gotz, J., Chen, F., Barmettler, R., and Nitsch, R. M. (2001) Tau filament formation in transgenic mice expressing P301L tau, J. Biol. Chem. 276, 529-534.
8. Hall, G. F., Chu, B., Lee, G., and Yao, J. (2000) Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease, J. Cell. Sci. 113, 1373-1387.
9. Hall, G. F., Lee, V. M., Lee, G., and Yao, J. (2001) Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy, Am. J. Pathol. 158, 235-246.
10. Hall, G. F., Chu, B., Lee, S., Liu, Y., and Yao, J. (2000) The single neurofilament subunit of the lamprey forms filaments and regulates axonal caliber and neuronal size in vivo, Cell. Motil. Cytoskeleton. 46, 166-182.
11. King, M. E., Ahuja, V., Binder, L. I., and Kuret, J. (1999) Ligand-dependent tau filament formation: implications for Alzheimer's disease progression, Biochemistry 38, 14851-14859.
12. Wilson, D. M., and Binder, L. I. (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease, Am. J. Pathol. 150, 2181-2195.
13. Chirita, C. N., Necula, M., and Kuret, J. (2003) Anionic Micelles and Vesicles Induce Tau Fibrillization in Vitro, J. Biol. Chem. 278, 25644-25650.
14. Barghorn, S., and Mandelkow, E. (2002) Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments, Biochemistry 41, 14885-14896.
15. King, M. E., Ghoshal, N., Wall, J. S., Binder, L. I., and Ksiezak-Reding, H. (2001) Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments, Am. J. Pathol. 158, 1481-1490.
16. Gamblin, T. C., King, M. E., Dawson, H., Vitek, M. P., Kuret, J., Berry, R. W., and Binder, L. I. (2000) In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants, Biochemistry 39, 6136-6144.
17. Abraha, A., Ghoshal, N., Gamblin, T. C., Cryns, V., Berry, R. W., Kuret, J., and Binder, L. I. (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease, J. Cell. Sci. 113, 3737-3745.
18. Berriman, J., Serpell, L. C., Oberg, K. A., Fink, A. L., Goedert, M., and Crowther, R. A. (2003) Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure, Proc. Natl. Acad. Sci. U.S.A. 100, 9034-9038.
19. von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E. M., and Mandelkow, E. (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure, Proc. Natl. Acad. Sci. U.S.A. 97, 5129-5134.
20. Chirita, C. N., and Kuret, J. (2004) Evidence for an intermediate in tau filament formation, Biochemistry 43, in press.
21. Wischik, C. M., Edwards, P. C., Lai, R. Y., Roth, M., and Harrington, C. R. (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines, Proc. Natl. Acad. Sci. U.S.A. 93, 11213-11218.
22. Carmel, G., Mager, E. M., Binder, L. I., and Kuret, J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology, J. Biol. Chem. 271, 32789-32795.
23. King, M. E., Gamblin, T. C., Kuret, J., and Binder, L. I. (2000) Differential assembly of human tau isoforms in the presence of arachidonic acid, J. Neurochem. 74, 1749-1757.
24. Necula, M., Chirita, C. N., and Kuret, J. (2003) Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro, J. Biol. Chem. 278, 46674-46680.
25. Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., and Holzman, T. F. (1994) Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths, Biophys. J. 67, 1216-1228.
26. Evans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H., and Lansbury, P. T., Jr. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 92, 763-767.
27. Uversky, V. N., Li, J., and Fink, A. L. (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation, J. Biol. Chem. 276, 10737-10744.
28. Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., and Crowther, R. A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease, Neuron 3, 519-526.
29. Masel, J., and Jansen, V. A. (2000) Designing drugs to stop the formation of prion aggregates and other amyloids, Biophys. Chem. 88, 47-59.
30. Kristofferson, D., Karr, T. L., and Purich, D. L. (1980) Dynamics of linear protein polymer disassembly, J. Biol. Chem. 255, 8567-8572.
31. Wilson, D. M., and Binder, L. I. (1995) Polymerization of microtubule-associated protein tau under near-physiological conditions, J. Biol. Chem. 270, 24306-24314.
32. Gamblin, T. C., King, M. E., Kuret, J., Berry, R. W., and Binder, L. I. (2000) Oxidative regulation of fatty acid-induced tau polymerization, Biochemistry 39, 14203-14210.
33. Briehl, R. W., Mann, E. S., and Josephs, R. (1990) Length distributions of hemoglobin S fibers, J. Mol. Biol. 211, 693-698.
34. Agarwal, G., Wang, J. C., Kwong, S., Cohen, S. M., Ferrone, F. A., Josephs, R., and Briehl, R. W. (2002) Sickle hemoglobin fibers: mechanisms of depolymerization, J. Mol. Biol. 322, 395-412.
35. Caprathe, B. W., Gilmore, J. L., Hays, S. J., Jaen, J. C., and LeVine, H. (1999), U.S. Patent 6 001 331.
36. Heiser, V., Engemann, S., Brocker, W., Dunkel, I., Boeddrich, A., Waelter, S., Nordhoff, E., Lurz, R., Schugardt, N., Rautenberg, S., Herhaus, C., Barnickel, G., Bottcher, H., Lehrach, H., and Wanker, E. E. (2002) Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay, Proc. Natl. Acad. Sci. U.S.A. 99, 16400-16406.
37. Kuner, P., Bohrmann, B., Tjernberg, L. O., Naslund, J., Huber, G., Celenk, S., Gruninger-Leitch, F., Richards, J. G., Jakob-Roetne, R., Kemp, J. A., and Nordstedt, C. (2000) Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands, J. Biol. Chem. 275, 1673-1678.
38. Lashuel, H. A., Hartley, D. M., Balakhaneh, D., Aggarwal, A., Teichberg, S., and Callaway, D. J. (2002) New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease, J. Biol. Chem. 277, 42881-42890.
39. Rudyk, H., Vasiljevic, S., Hennion, R. M., Birkett, C. R., Hope, J., and Gilbert, I. H. (2000) Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells, J. Gen. Virol. 81, 1155-1164.
40. Lorenzo, A., and Yankner, B. A. (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red, Proc. Natl. Acad. Sci. U.S.A. 91, 12243-12247.
41. Peterson, S. A., Klabunde, T., Lashuel, H. A., Purkey, H., Sacchettini, J. C., and Kelly, J. W. (1998) Inhibiting transthyretin conformational changes that lead to amyloid fibril formation, Proc. Natl. Acad. Sci. U.S.A. 95, 12956-12960.
42. Skoufias, D. A., and Wilson, L. (1992) Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes, Biochemistry 31, 738-746.
43. Perez-Ramirez, B., Andreu, J. M., Gorbunoff, M. J., and Timasheff, S. N. (1996) Stoichiometric and substoichiometric inhibition of tubulin self-assembly by colchicine analogues, Biochemistry 35, 3277-3285.
44. Schweers, O., Schonbrunn-Hanebeck, E., Marx, A., and Mandelkow, E. (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta structure, J. Biol. Chem. 269, 24290-24297.
45. Klunk, W. E., Pettegrew, J. W., and Abraham, D. J. (1989) Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation, J. Histochem. Cytochem. 37, 1273-1281.
46. Khurana, R., Uversky, V. N., Nielsen, L., and Fink, A. L. (2001) Is Congo red an amyloid-specific dye? J. Biol. Chem. 276, 22715-22721.
47. Tobacman, L. S., and Korn, E. D. (1983) The kinetics of actin nucleation and polymerization, J. Biol. Chem. 258, 3207-3214.
48. Pertinhez, T. A., Bouchard, M., Smith, R. A. G., Dobson, C. M., and Smith, L. J. (2002) Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS, FEBS Lett. 529, 193-197.
49. Ahmad, A., Millett, I. S., Doniach, S., Uversky, V. N., and Fink, A. L. (2003) Partially folded intermediates in insulin fibrillation, Biochemistry 42, 11404-11416.
50. Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., and Fink, A. L. (2001) Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates, Biochemistry 40, 3525-3535.
51. Gomez-Isla, T., Price, J. L., McKeel, D. W., Jr., Morris, J. C., Growdon, J. H., and Hyman, B. T. (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease, J. Neurosci. 16, 4491-4500.
52. Ghoshal, N., Garcia-Sierra, F., Wuu, J., Leurgans, S., Bennett, D. A., Berry, R. W., and Binder, L. I. (2002) Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease, Exp. Neurol. 177, 475-493.
53. Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., and Ghetti, B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia, Proc. Natl. Acad. Sci. U.S.A. 95, 7737-7741.
54. Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R. C., Stevens, M., de Graaff, E., Wauters, E., van Baren, J., Hillebrand, M., Joosse, M., Kwon, J. M., Nowotny, P., Heutink, P. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17, Nature 393, 702-705.
55. Hasegawa, M., Smith, M. J., and Goedert, M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly, FEBS Lett 437, 207-210.
56. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B. I., Geschwind, D. H., Bird, T. D., McKeel, D., Goate, A., Morris, J. C., Wilhelmsen, K. C., Schellenberg, G. D., Trojanowski, J. Q., and Lee, V. M. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17, Science 282, 1914-1917.
57. Goedert, M., Jakes, R., and Crowther, R. A. (1999) Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments, FEBS Lett 450, 306-311.
58. Reed, L. A., Schmidt, M. L., Wszolek, Z. K., Balin, B. J., Soontomniyomkij, V., Lee, V. M., Trojanowski, J. Q., and Schelper, R. L. (1998) The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia (pallidoponto-nigral degeneration), J. Neuropathol. Exp. Neurol. 57, 588-601.
59. Khatoon, S., Grundke-Iqbal, I., and Iqbal, K. (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein, J. Neurochem. 59, 750-753.
60. Perry, G., Kawai, M., Tabaton, M., Onorato, M., Mulvihill, P., Richey, P., Morandi, A., Connolly, J. A., and Gambetti, P. (1991) Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton, J. Neurosci. 11, 1748-1755.